August 2013 FDA Recall Lidocaine by Novocol Pharmaceutical Of Canada
D-923-2013 - Subpotent Drug; Two lots of Lidocaine 2% with Epinephrine 1

This Class II drug recall was voluntarily initiated by Novocol Pharmaceutical Of Canada on August 14, 2013 for the product Lidocaine. The FDA reported the reason for recall as subpotent drug; two lots of lidocaine 2% with epinephrine 1. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-923-2013

Reason for Recall
Subpotent Drug; Two lots of Lidocaine 2% with Epinephrine 1:100,000 Injectable, distributed under the names: Octocaine 100, and 2% Xylocaine Dental, may be subpotent for the epinephrine component.
Initiated
08-14-2013
Reported
09-04-2013
Quantity
12,497 Boxes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Novocol Pharmaceutical of Canada
Nationwide and Canada
Lidocaine Hydrochloride 2% and Epinephrine 1:100,000 Injection, Rx Only, For Dental Block and Infiltration Only, 50 Cartridges per box - 1.7 mL minimum each, NDC #s: a) Octocaine 100, Mfr'ed for Septodont, Louisville, CO, 80027, by Novocol Pharmaceutical of Canada, Inc., Cambridge, Ontario, Canada N1R6X3, 0362-9023-05; b) Superdent, Dist by: Darby Dental Supply Co., Jericho, NY 11753, Made in Canada, 66467-9730-5; and c) Dist by: IQ Dental, 353 Rt 46 W, Bldg C Unit 120, Fairfield, NJ, 07004, made in Canada, 42756-1030-5; Manufactured by: by Novocol Pharmaceutical of Canada, Inc., Cambridge, Ontario, Canada N1R6X3.

Batch or Lot Expiration Information

Lot# s: D00290 D, Exp 08/2013; D00205 A, Exp 11/2013

Affected Packages Involved in this Recall